NTRK1 and glioblastoma: In general, receptor tyrosine kinases (RTKs) are dysregulated in approximately 90% of GBM, and often platelet-derived growth factor receptor (PDGFR) and epidermal growth factor receptor (EGFR) are amplified or mutated in GBM [52,53].